+Follow
Glorious
No personal profile
29
Follow
0
Followers
0
Topic
0
Badge
Posts
Hot
Glorious
2020-02-10
10.7？
JPMorgan: Maintain Alibaba Health (00241) "overweight" rating with a target price of HK $10.7
Go to Tiger App to see more news
{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3486434274927095","uuid":"3486434274927095","gmtCreate":1523340255413,"gmtModify":1704447500880,"name":"Glorious","pinyin":"glorious","introduction":"","introductionEn":"","signature":"","avatar":"https://static.laohu8.com/7f9c7f1d9264bb8351b6c78498c677e3","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":29,"tweetSize":2,"questionSize":0,"limitLevel":900,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":4,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"44212b71d0be4ec88898348dbe882e03-1","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Boss Tiger","description":"The transaction amount of the securities account reaches $100,000","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"60.28%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"972123088c9646f7b6091ae0662215be-2","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Master Trader","description":"Total number of securities or futures transactions reached 100","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"80.98%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":3,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":914689903,"gmtCreate":1581309233902,"gmtModify":1705425803502,"author":{"id":"3486434274927095","authorId":"3486434274927095","name":"Glorious","avatar":"https://static.laohu8.com/7f9c7f1d9264bb8351b6c78498c677e3","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3486434274927095","idStr":"3486434274927095"},"themes":[],"htmlText":"10.7？","listText":"10.7？","text":"10.7？","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/914689903","repostId":"2010240500","repostType":2,"repost":{"id":"2010240500","kind":"news","pubTimestamp":1581307330,"share":"https://ttm.financial/m/news/2010240500?lang=en_US&edition=fundamental","pubTime":"2020-02-10 12:02","market":"hk","language":"zh","title":"JPMorgan: Maintain Alibaba Health (00241) \"overweight\" rating with a target price of HK $10.7","url":"https://stock-news.laohu8.com/highlight/detail?id=2010240500","media":"智通财经","summary":"智通财经APP获悉，小摩发布报告称，阿里健康(00241)日前公布向母公司阿里巴巴(09988)收购天猫药品销售平台，目标业务于截至去年3月底止年度产生总交易金额约95.75亿元人民币，交易总对价80","content":"<p><div>Zhitong Finance APP learned that JPMorgan released a report saying that Alibaba Health (00241) recently announced the acquisition of the Tmall drug sales platform from its parent company Alibaba (09988). RMB, the total transaction consideration is 8.075 billion yuan, equivalent to approximately 0.76 times the valuation/total transaction volume of the platform. The bank added that it has a positive sense of the above-mentioned transactions, and said that the timing of injecting the drug business is good, which will help Alibaba Health develop an online prescription drug sales platform in the mainland and further strengthen Alibaba Health's position as the flagship platform of Alibaba's big health. It believes...</p><p><a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2020021012110379a7cd18&s=b\">Web link</a></div></p>","source":"tencent","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>JPMorgan: Maintain Alibaba Health (00241) \"overweight\" rating with a target price of HK $10.7</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJPMorgan: Maintain Alibaba Health (00241) \"overweight\" rating with a target price of HK $10.7\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">智通财经</strong><span class=\"h-time small\">2020-02-10 12:02</span>\n</p>\n</h4>\n</header>\n<article>\n<p><div>Zhitong Finance APP learned that JPMorgan released a report saying that Alibaba Health (00241) recently announced the acquisition of the Tmall drug sales platform from its parent company Alibaba (09988). RMB, the total transaction consideration is 8.075 billion yuan, equivalent to approximately 0.76 times the valuation/total transaction volume of the platform. The bank added that it has a positive sense of the above-mentioned transactions, and said that the timing of injecting the drug business is good, which will help Alibaba Health develop an online prescription drug sales platform in the mainland and further strengthen Alibaba Health's position as the flagship platform of Alibaba's big health. It believes...</p><p><a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2020021012110379a7cd18&s=b\">Web link</a></div></p>\n<div class=\"bt-text\">\n\n\n<p> source：<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2020021012110379a7cd18&s=b\">智通财经</a></p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/331014881ee5d50c3f903d427c33934b","relate_stocks":{"00241":"阿里健康","JPM":"摩根大通"},"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2020021012110379a7cd18&s=b","is_english":false,"share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","article_id":"2010240500","content_text":"智通财经APP获悉，小摩发布报告称，阿里健康(00241)日前公布向母公司阿里巴巴(09988)收购天猫药品销售平台，目标业务于截至去年3月底止年度产生总交易金额约95.75亿元人民币，交易总对价80.75亿元，相当于估值/平台总交易额约0.76倍。该行补充，对上述交易感正面，更称注入药物业务的时机佳，将有助阿里健康开拓内地网上处方药销售平台，更强化阿里健康作为阿里巴巴大健康旗舰平台的地位，相信短期内对阿里健康股价会有正面刺激作用。该行表示，维持其“增持”评级，目标价10.7港元。","news_type":1,"symbols_score_info":{"JPM":0.6,"00241":0.6}},"isVote":1,"tweetType":1,"viewCount":1575,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":914689903,"gmtCreate":1581309233902,"gmtModify":1705425803502,"author":{"id":"3486434274927095","authorId":"3486434274927095","name":"Glorious","avatar":"https://static.laohu8.com/7f9c7f1d9264bb8351b6c78498c677e3","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3486434274927095","idStr":"3486434274927095"},"themes":[],"htmlText":"10.7？","listText":"10.7？","text":"10.7？","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/914689903","repostId":"2010240500","repostType":2,"repost":{"id":"2010240500","kind":"news","pubTimestamp":1581307330,"share":"https://ttm.financial/m/news/2010240500?lang=en_US&edition=fundamental","pubTime":"2020-02-10 12:02","market":"hk","language":"zh","title":"JPMorgan: Maintain Alibaba Health (00241) \"overweight\" rating with a target price of HK $10.7","url":"https://stock-news.laohu8.com/highlight/detail?id=2010240500","media":"智通财经","summary":"智通财经APP获悉，小摩发布报告称，阿里健康(00241)日前公布向母公司阿里巴巴(09988)收购天猫药品销售平台，目标业务于截至去年3月底止年度产生总交易金额约95.75亿元人民币，交易总对价80","content":"<p><div>Zhitong Finance APP learned that JPMorgan released a report saying that Alibaba Health (00241) recently announced the acquisition of the Tmall drug sales platform from its parent company Alibaba (09988). RMB, the total transaction consideration is 8.075 billion yuan, equivalent to approximately 0.76 times the valuation/total transaction volume of the platform. The bank added that it has a positive sense of the above-mentioned transactions, and said that the timing of injecting the drug business is good, which will help Alibaba Health develop an online prescription drug sales platform in the mainland and further strengthen Alibaba Health's position as the flagship platform of Alibaba's big health. It believes...</p><p><a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2020021012110379a7cd18&s=b\">Web link</a></div></p>","source":"tencent","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>JPMorgan: Maintain Alibaba Health (00241) \"overweight\" rating with a target price of HK $10.7</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJPMorgan: Maintain Alibaba Health (00241) \"overweight\" rating with a target price of HK $10.7\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">智通财经</strong><span class=\"h-time small\">2020-02-10 12:02</span>\n</p>\n</h4>\n</header>\n<article>\n<p><div>Zhitong Finance APP learned that JPMorgan released a report saying that Alibaba Health (00241) recently announced the acquisition of the Tmall drug sales platform from its parent company Alibaba (09988). RMB, the total transaction consideration is 8.075 billion yuan, equivalent to approximately 0.76 times the valuation/total transaction volume of the platform. The bank added that it has a positive sense of the above-mentioned transactions, and said that the timing of injecting the drug business is good, which will help Alibaba Health develop an online prescription drug sales platform in the mainland and further strengthen Alibaba Health's position as the flagship platform of Alibaba's big health. It believes...</p><p><a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2020021012110379a7cd18&s=b\">Web link</a></div></p>\n<div class=\"bt-text\">\n\n\n<p> source：<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2020021012110379a7cd18&s=b\">智通财经</a></p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/331014881ee5d50c3f903d427c33934b","relate_stocks":{"00241":"阿里健康","JPM":"摩根大通"},"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2020021012110379a7cd18&s=b","is_english":false,"share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","article_id":"2010240500","content_text":"智通财经APP获悉，小摩发布报告称，阿里健康(00241)日前公布向母公司阿里巴巴(09988)收购天猫药品销售平台，目标业务于截至去年3月底止年度产生总交易金额约95.75亿元人民币，交易总对价80.75亿元，相当于估值/平台总交易额约0.76倍。该行补充，对上述交易感正面，更称注入药物业务的时机佳，将有助阿里健康开拓内地网上处方药销售平台，更强化阿里健康作为阿里巴巴大健康旗舰平台的地位，相信短期内对阿里健康股价会有正面刺激作用。该行表示，维持其“增持”评级，目标价10.7港元。","news_type":1,"symbols_score_info":{"JPM":0.6,"00241":0.6}},"isVote":1,"tweetType":1,"viewCount":1575,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}
